Salute e Benessere

Inside information: Bioretec updates its financial targets

Due to the acceleration of the product development of the RemeOs™ Spinal Interbody Cage, Bioretec's Board of Directors has today updated Bioretec's financial targets as follows: Due to the acceleration of the product development of the RemeOs™ Spinal Interbody Cage, Bioretec's Board of Directors has today updated Bioretec's financial targets as follows: The previously communicatedEUR 62 millionnet sales target and the timing of reaching cash flow positive stage from operating activities...
PR Newswire
04/10/2024

IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by…

Each Unit will be comprised of one Share and one Share purchase warrant (each, a "Warrant"). Each Warrant shall entitle the holder thereof to acquire one additional Share (each, a "Warrant Share) at a price equal to a 50% premium to the Offering Price (the "Warrant Exercise Price") at any time prior to 5:00 p.m. (Toronto time) on second anniversary of the closing date. The Offering, which is expected to close in one or more tranches, will be led by the Company's…
PR Newswire
04/10/2024

Piramal Pharma releases its Sustainability Report for FY 2023-24 under the…

Nandini Piramal, Chairperson of Piramal Pharma Ltd., said, "As we advance on our sustainability journey, we are deeply committed to transparency, accountability, and continuous improvement in our business practices. Our latest Sustainability Report not only highlights the milestones we've achieved but also demonstrates our capability to adapt to evolving global standards. By revising our Scope 1 and 2 GHG emissions and energy consumption for FY 2023, we have significantly improved data…
PR Newswire
04/10/2024

Clarivate in partnership with Abiquifi Announces Annual Summit LATAM Agenda

In the wake of the pandemic, the global pharmaceutical industry faced a slowdown in growth, prompting companies to swiftly identify new opportunities and areas of innovation. As the Latin American market is valued at $98 billion,1 with projected growth of 10.1%—outpacing North America (3.1%) and Europe (3.9%)—navigating this region is crucial for the future of the global pharmaceutical landscape. To maintain a competitive edge and ensure return on investment, organizations must adopt effective…
PR Newswire
04/10/2024

MD Logistics to Open State-of-the-art Dedicated Pharmaceutical Warehouse in…

NX Logo: https://kyodonewsprwire.jp/img/202409277148-O3-nAkv058x NX Logo:https://kyodonewsprwire.jp/img/202409277148-O3-nAkv058x Exterior view of warehouse:https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202409277148/_prw_PI1fl_PVWX1sAF.jpg Interior view of refrigerated warehouse:https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202409277148/_prw_PI2fl_3UA9VL4y.jpg Indianais known as the pharmaceutical manufacturing capital of the Midwest and is home to...
PR Newswire
04/10/2024

Orexo´s Nomination Committee for the Annual General Meeting 2025

The Nomination Committee will prepare proposals to the AGM regarding Chairman of the meeting, Chairman of the Board, Board members, Board member fees, any remuneration for committee work, and fees to the auditor, as well as principles for the composition of the Nomination Committee. The Nomination Committee will prepare proposals to the AGM regarding Chairman of the meeting, Chairman of the Board, Board members, Board member fees, any remuneration for committee work, and fees to the auditor…
PR Newswire
04/10/2024

RECORDATI ANNOUNCES AGREEMENT TO ACQUIRE THE GLOBAL RIGHTS TO ENJAYMO®…

Milan, 4 thOctober 2024– Recordati today announces an agreement with Sanofi to acquire the global rights to Enjaymo® (sutimlimab), a biologic which is the only approved targeted product for the treatment of cold agglutinin disease (CAD), a rare B-cell lymphoproliferative disorder.Enjaymo® (sutimlimab) is a humanized monoclonal antibody indicated for the treatment of hemolysis in adults with CAD. In 2022, it was granted approval by the U.S. Food and Drug Administration...
Nasdaq GlobeNewswire
04/10/2024

Valneva SE - Declaration of shares and voting rights - September 30, 2024

VALNEVADeclaration of shares and voting rightsSeptember 30, 2024__________________________________________________________________________________________Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France) Regulated market of Euronext Paris - Compartment B Declaration date: October 4, 2024 Number of sharescomposing the share capital of ValnevaTotal number of voting rights including suspended voting rights* Description of the...
Nasdaq GlobeNewswire
04/10/2024

ABL Bio Announces Clinical Collaboration to Evaluate ABL103 in Combination with…

Under the terms of the agreement, ABL Bio will conduct a phase 1b/2 clinical trial to evaluate the safety and efficacy of ABL103 in combination with KEYTRUDA. In this combination study, MSD will supply KEYTRUDA. Under the terms of the agreement, ABL Bio will conduct a phase1b /2 clinical trial to evaluate the safety and efficacy of ABL103 in combination with KEYTRUDA. In this combination study, MSD will supply KEYTRUDA. ABL103 is bispecific antibody that simultaneously targets B7-H4 and...
PR Newswire
04/10/2024

Global Telemedicine Market to Cross ~USD 14 Billion by 2030 | DelveInsight

Key Takeaways from the Telemedicine Market Report Key Takeaways from the Telemedicine Market Report To read more about the latest highlights related to the telemedicine market, get a snapshot of the key highlights entailed in the Global Telemedicine Market Report Telemedicine Overview Telemedicine has revolutionized the healthcare landscape by making medical consultations more accessible and convenient. Through the use of digital communication tools, patients can now connect...
PR Newswire
03/10/2024

Casino Group: Confirmation of a repayment to Quatrim secured bondholders

Confirmation of a repaymentto Quatrim secured bondholders Paris, 3 October 2024Following the sale on September 26, 2024 of a portfolio of real estate assets 1, Casino Group announces that it has made yesterday a payment of €198.7m to holders of the secured bonds of its subsidiary Quatrim, including €190.4m in principal and €8.3m in accrued interest.The nominal amount of Quatrim's secured bonds has thus been reduced to €300.5m.In addition, an interest payment will take place on...
Nasdaq GlobeNewswire
03/10/2024

Global Health Exhibition Expands International Footprint with Worldwide…

"The Global Health Exhibition truly lives up to its name with attendees joining the event from all corners of the world, enriching opportunities for mutually-beneficial country-to-country networking with key experts and learning in a high-tech environment," said Rachel Sturgess, Group Director, Tahaluf, the event's organizer. "The Global Health Exhibition truly lives up to its name with attendees joining the event from all corners of the world, enriching opportunities for…
PR Newswire
03/10/2024

Dark Horse Consulting Group Acquires BioTechLogic, Inc.

Combined organization to offer strategic advisory, operations, and technical consulting across the biopharma industry Dark Horse Consulting Group(“DHC”), the longstanding global leader in strategic and operational consulting in the field of cell and gene therapy (“CGT”), is delighted to announce the acquisition ofBioTechLogic, Inc.(“BioTechLogic”), a recognized forerunner in technical operations, manufacturing, quality, and regulatory CMC consulting. This strategic acquisition marks a...
Nasdaq GlobeNewswire
03/10/2024

Clinical Trial Imaging Market to Hit USD 2.07 Billion by 2029 with 7.8% CAGR |…

Browse in-depth TOC on "Clinical Trial Imaging Market" Browse in-depth TOC on "Clinical Trial Imaging Market" 311 - Tables 48 - Figures 248 - Pages The clinical trial imaging market is divided into two segments: services and software. By far the largest share of the clinical trial imaging market in 2023 belonged to the services segment. One of the main reasons for this segment's considerable domination is the high cost of imaging equipment. This element has fueled the trend…
PR Newswire
03/10/2024

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2024

Sales in Zinzino's sales markets increased by 22% in the third quarter of 2024 compared with the same period last year and amounted to SEK 503.9 (413.8) million. Total revenues in the Group increased by 22 % in the third quarter and amounted to SEK 531.9 (436.9) million. Sales in Zinzino's sales markets increased by 22% in the third quarter of 2024 compared with the same period last year and amounted toSEK 503.9(413.8) million. Total revenues in the Group increased by 22 % in the third...
PR Newswire
03/10/2024

Dental Drills & Burs Market Set for Significant Expansion Projected to Reach USD…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1043749 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1043749 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Dental Drills & Burs Market Overview Geographic Dominance : The Dental Drills & Burs Market displays notable geographic dominance across various regions, each contributing uniquely to the market's growth. North...
PR Newswire
03/10/2024

IBC launches RadSep, Inc.: Best-in-class, highly selective separations using…

MRT™ ligands are tailored to target specific ions in terms of matching their shapes and co-ordination chemistry. These molecules are covalently attached to support materials such as organic polymers or silicates to create reusable MRT™ resins that bind metals with exceptional selectivity in packed column mode, including radioisotopes of radium, lead, thorium, actinium, bismuth, copper and others. The bound target radioisotope is removed via elution with very high rates of purity and recovery, up…
PR Newswire
03/10/2024

Medical Grade Silicone Market Surges to USD 3.6 Billion by 2030, Propelled by…

Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=629644 Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=629644 Browse in-depth TOC onMedical Grade Silicone Market 202 – Pages 126 – Tables 37 – Figures Scope of The Report Global Medical Grade Silicone Market Overview Market Drivers Fueling Growth in the Medical Grade Silicone Market Increasing Demand for Medical Devices and Implants The...
PR Newswire
03/10/2024

Custom Foot Orthotic Insoles Market Projected to Reach $5.2 Billion by 2031…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1042869 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1042869 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Custom Foot Orthotic Insoles Market Overview 1.Market Size and Growth : The global Custom Foot Orthotic Insoles Market is poised for significant expansion, with projections indicating a rise from approximatelyUSD 3...
PR Newswire
03/10/2024

Hip Replacement Implants Market is expected to generate a revenue of USD 8.44…

With the increasing prevalence of osteoarthritis, trauma, and bone degeneration, the demand for hip replacement implants has surged globally, making it a key focus area for healthcare providers, medical device manufacturers, and suppliers. Our latest report offers a detailed examination of market dynamics, cutting-edge technologies, regulatory challenges, and strategic growth opportunities. With the increasing prevalence of osteoarthritis, trauma, and bone degeneration, the demand for hip...
PR Newswire
03/10/2024

Coronado Research announce engagement of Rob Nichols to support the growth of…

Nichols commented, "Andrew and I met at an industry event many years ago, and our paths have crossed ever since. We both sat on the board of the Association for Clinical Data Management together and then held senior leadership roles in pharma services and technology companies, at times partnering to provide technology-enabled solutions. It is very exciting to have the opportunity to support Andrew and his team in developing an industry-leading approach to optimising clinical development…
PR Newswire
03/10/2024

Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's…

Click here to view the custom infographic of the Annovis Bio editorial. Clickhere to view the custom infographic of the Annovis Bio editorial. Buntanetap Targeting Alzheimer's Disease Annovis Bio Inc. (NYSE: ANVS) is leading efforts to develop innovative and safe treatments for neurodegenerative diseases such as Alzheimer's. The company's main focus is enhancing nerve cell health to improve cognition in such conditions, a target that has proved elusive for peers. The company's...
PR Newswire
03/10/2024

Teva and mAbxience Expand Strategic Partnership to include an additional…

The expansion of the strategic partnership reinforces the solid foundation of the collaborative efforts that commenced in April 2024The collaboration supports Teva's Pivot to Growth strategy and adds to the company's biosimilar portfolio Both companies reaffirm their shared commitment to making high-quality, affordable treatments accessible to patients worldwide TEL AVIV, ISRAEL and MADRID, Oct.03, 2024(GLOBE NEWSWIRE) -- Teva Pharmaceuticals International GmbH, a...
Nasdaq GlobeNewswire
03/10/2024

Theriva™ Biologics Announces Positive Outcome of Data and Safety Monitoring…

DSMC has reviewed the safety and pharmacokinetic data from Cohort 2 and recommended that the study proceed to enroll patients into Cohort 3 /2a randomized, double-blinded, placebo-controlled clinical trial of SYN-004 (ribaxamase) in allogeneic hematopoietic cell transplant (HCT) recipients for the prevention of acute graft-versus-host-disease (aGVHD).Cohort 2 enrolled 19 patients who received at least 1 dose of study drug (SYN-004 or Placebo randomized 2:1). Eighteen (18) patients received...
Nasdaq GlobeNewswire
03/10/2024
Altri  Comunicati